Introduction
Y-90 therapy, also known as Yttrium-90 radioembolization, is a targeted internal radiation treatment used primarily for liver tumors, including both primary liver cancer and liver metastases.
The therapy delivers high-dose radiation directly to tumors through tiny radioactive microspheres injected into the liver’s blood supply.
By targeting tumors from within while sparing most healthy liver tissue, Y-90 therapy offers an effective treatment option for patients who may not be candidates for surgery or other local therapies.
It is performed by specialized interventional radiology and nuclear medicine teams using advanced imaging guidance.
Türkiye is a trusted destination for interventional oncology and nuclear medicine therapies, offering experienced specialists, modern angiography suites, and integrated cancer care.
Averia Health supports international patients through ethical, structured, and fully coordinated Y-90 therapy focused on safety, precision, and continuity of care.
Why Choose Türkiye for Y-90 Therapy
Türkiye is internationally recognized for advanced liver cancer treatments because of:
- Experienced interventional radiologists and nuclear medicine physicians
- Advanced angiography and imaging-guided treatment facilities
- Multidisciplinary liver tumor boards
- Strict radiation safety and quality control protocols
- Modern hospitals with intensive care support
- Internationally accredited medical centers
Türkiye combines technical expertise with comprehensive oncologic care.
Why Choose Averia Health
Averia Health provides comprehensive coordination for Y-90 radioembolization:
- Pre-arrival review of medical history, imaging, and oncology reports
- Multidisciplinary case coordination (oncology, radiology, nuclear medicine)
- Referral to experienced Y-90 therapy centers
- Clear explanation of treatment goals, benefits, and limitations
- Personalized treatment planning
- Professional interpreter services
- 24/7 patient support during your stay
- Post-treatment follow-up and international oncology coordination
Our approach prioritizes safety, transparency, and informed decision-making.
Conditions Treated with Y-90 Therapy
Y-90 therapy may be recommended for:
- Hepatocellular carcinoma (primary liver cancer)
- Liver metastases from colorectal cancer
- Liver-dominant metastatic disease from other cancers
- Tumors not suitable for surgical removal
- Tumors not responding adequately to systemic therapy
Eligibility depends on liver function, tumor distribution, and overall health.
Diagnostic Evaluation Before Y-90 Therapy
Comprehensive evaluation may include:
- CT or MRI imaging of the liver
- PET-CT in selected cases
- Liver function tests
- Blood tests and coagulation profile
- Angiographic mapping procedure
- Lung shunt assessment
Accurate planning ensures safe and effective treatment delivery.
How Y-90 Therapy Works
Mapping Angiography
A preliminary procedure maps liver blood vessels and identifies non-target branches.
Microsphere Delivery
Yttrium-90–loaded microspheres are delivered directly into tumor-feeding arteries.
Targeted Radiation
Radiation is released locally within the tumor over time, limiting exposure to healthy tissue.
Post-Treatment Monitoring
Patients are monitored for side effects and liver function.
The procedure is minimally invasive and performed via catheter-based techniques.
Treatment Journey in Türkiye
- Pre-Arrival Case Review
Medical records and imaging are reviewed in advance. - Multidisciplinary Evaluation
Suitability for Y-90 therapy is confirmed. - Treatment Planning & Mapping
Angiographic planning and safety checks are completed. - Y-90 Radioembolization
Therapy is administered by experienced specialists. - Post-Treatment Care & Monitoring
Recovery, symptom management, and liver function are monitored. - Follow-Up & Oncologic Continuity
Imaging follow-up and ongoing cancer care are coordinated internationally.
Expected Results & Benefits
- Targeted treatment of liver tumors
- Local tumor control or reduction
- Preservation of healthy liver tissue
- Outpatient or short hospital stay
- Option for patients with limited alternatives
Response varies based on tumor type and liver function.
Risks & Considerations
Y-90 therapy is generally well tolerated but may include:
- Fatigue
- Abdominal discomfort or nausea
- Temporary changes in liver enzymes
- Rare risk of radiation injury to non-target tissue
- Need for follow-up imaging and monitoring
All potential risks are explained clearly before treatment.
What’s Included in Your Medical Trip
- Oncology and interventional radiology consultations
- Imaging and laboratory review
- Mapping angiography procedure
- Y-90 radioembolization therapy
- Hospital and procedural services
- Post-treatment monitoring and medications
- Interpreter services
- 24/7 patient support
- International follow-up coordination
Averia Health ensures ethical, precise, and patient-centered interventional oncology care.
Frequently Asked Questions
Is Y-90 therapy chemotherapy?
No. It is a targeted internal radiation therapy.
Will I need surgery after Y-90 therapy?
Some patients may become eligible for surgery later; others use it as definitive treatment.
Is hospitalization required?
Many patients are treated on an outpatient basis or with a short stay.
Can Y-90 therapy be repeated?
In selected cases, repeat treatment may be considered.
Can international patients receive Y-90 therapy in Türkiye?
Yes. Full coordination and follow-up are provided.
Ready to Start Your Health Journey?
Access advanced, targeted liver tumor treatment with Y-90 radioembolization therapy in Türkiye.
Request a free quote or contact us on WhatsApp to speak with our interventional oncology coordination team.
